Global Fertility Drugs
Global Fertility Drugs

Fertility Drugs Comprehensive Study by Type (Prescription Fertility Drugs, Over-The-Counter Fertility drugs), Application (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes), Patient Type (Female fertility, Male fertility), Route of Administration (Intravenous, Subcutaneous, Intramuscular), Use ` (Metformin (Glucophage), Dopamine agonists, Clomiphene (Clomid):, Letrozole (Femara), Gonadotropin) Players and Region - Global Market Outlook to 2025

Fertility Drugs Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Nov 2020 Edition 244 Pages 172 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Fertility Drugs Market?

One of the most significant medical advancements of the mid-20th century may have been the development of fertility drugs. The rise in the demand for increasing the chances of conceiving and carrying the baby to is booming the market demand as these medicines have made it possible for countless people to fulfill their dream of becoming parents. Fertility drugs are the main course of treatment for women who are infertile due to ovulation disorders such as irregular menstrual cycles. According to the research, done by the American Society for Reproductive Medicine (ASRM), about 25 percent of infertile women have problems with ovulation.

The market study is being classified by Type (Prescription Fertility Drugs and Over-The-Counter Fertility drugs), by Application (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks and Research Institutes) and major geographies with country level break-up.

Merck & Co. (United States), Ferring Pharmaceuticals (Switzerland), Bayer (Germany), Berlex Laboratories Inc. (United States), Janssen Pharmaceutical Inc. (United States), Pfizer (United States), Novartis AG (Switzerland), Procter & Gamble Pharmaceutical (United States), Sanofi S.A (France) and Eli Lilly and Co.(United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Livzon Pharmaceutical Group Co., Ltd.(China).

The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Fertility Drugs market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Fertility Drugs market by Type, Application and Region.

On the basis of geography, the market of Fertility Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Number of Fertility Clinics Worldwide
  • The rising cases of infertility across the globe are increasing the demand for fertility drugs


Restraints
  • Risks of ovarian tumors
  • Risks and side effects of fertility drugs
  • Stringent government regulations

Opportunities
  • Increasing Use of Fertility Treatment Options By Single Parents and Same-Sex Couples

Challenges
  • Reduced Efficacy Among Older Women
  • The side effects caused due to fertility drugs restricted the growth of the fertility drugs


In December 2019 Mankind Pharma Launches Infertility Drug named Dydroboon launching this drug company to rank the first Indian and second global firm to develop drugs. It is a safe and effective drug as other drugs.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Fertility Drugs Manufacturer, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End Use Industry

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Prescription Fertility Drugs
  • Over-The-Counter Fertility drugs
By Application
  • Fertility Centers
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes
By Patient Type
  • Female fertility
  • Male fertility

By Route of Administration
  • Intravenous
  • Subcutaneous
  • Intramuscular

By Use `
  • Metformin (Glucophage)
  • Dopamine agonists
  • Clomiphene (Clomid):
  • Letrozole (Femara)
  • Gonadotropin

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Fertility Clinics Worldwide
      • 3.2.2. The rising cases of infertility across the globe are increasing the demand for fertility drugs
    • 3.3. Market Challenges
      • 3.3.1. Reduced Efficacy Among Older Women
      • 3.3.2. The side effects caused due to fertility drugs restricted the growth of the fertility drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fertility Drugs, by Type, Application, Patient Type, Route of Administration, Use ` and Region (value, volume and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Fertility Drugs (Value)
      • 5.2.1. Global Fertility Drugs by: Type (Value)
        • 5.2.1.1. Prescription Fertility Drugs
        • 5.2.1.2. Over-The-Counter Fertility drugs
      • 5.2.2. Global Fertility Drugs by: Application (Value)
        • 5.2.2.1. Fertility Centers
        • 5.2.2.2. Hospitals & Surgical Clinics
        • 5.2.2.3. Cryobanks
        • 5.2.2.4. Research Institutes
      • 5.2.3. Global Fertility Drugs by: Patient Type (Value)
        • 5.2.3.1. Female fertility
        • 5.2.3.2. Male fertility
      • 5.2.4. Global Fertility Drugs by: Route of Administration (Value)
        • 5.2.4.1. Intravenous
        • 5.2.4.2. Subcutaneous
        • 5.2.4.3. Intramuscular
      • 5.2.5. Global Fertility Drugs by: Use ` (Value)
        • 5.2.5.1. Metformin (Glucophage)
        • 5.2.5.2. Dopamine agonists
        • 5.2.5.3. Clomiphene (Clomid):
        • 5.2.5.4. Letrozole (Femara)
        • 5.2.5.5. Gonadotropin
      • 5.2.6. Global Fertility Drugs Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Fertility Drugs (Volume)
      • 5.3.1. Global Fertility Drugs by: Type (Volume)
        • 5.3.1.1. Prescription Fertility Drugs
        • 5.3.1.2. Over-The-Counter Fertility drugs
      • 5.3.2. Global Fertility Drugs by: Application (Volume)
        • 5.3.2.1. Fertility Centers
        • 5.3.2.2. Hospitals & Surgical Clinics
        • 5.3.2.3. Cryobanks
        • 5.3.2.4. Research Institutes
      • 5.3.3. Global Fertility Drugs by: Patient Type (Volume)
        • 5.3.3.1. Female fertility
        • 5.3.3.2. Male fertility
      • 5.3.4. Global Fertility Drugs by: Route of Administration (Volume)
        • 5.3.4.1. Intravenous
        • 5.3.4.2. Subcutaneous
        • 5.3.4.3. Intramuscular
      • 5.3.5. Global Fertility Drugs by: Use ` (Volume)
        • 5.3.5.1. Metformin (Glucophage)
        • 5.3.5.2. Dopamine agonists
        • 5.3.5.3. Clomiphene (Clomid):
        • 5.3.5.4. Letrozole (Femara)
        • 5.3.5.5. Gonadotropin
      • 5.3.6. Global Fertility Drugs Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Fertility Drugs (Price)
      • 5.4.1. Global Fertility Drugs by: Type (Price)
  • 6. Fertility Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ferring Pharmaceuticals (Switzerland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Berlex Laboratories Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Janssen Pharmaceutical Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pfizer (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Procter & Gamble Pharmaceutical (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sanofi S.A (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Eli Lilly and Co.(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Fertility Drugs Sale, by Type, Application, Patient Type, Route of Administration, Use ` and Region (value, volume and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Fertility Drugs (Value)
      • 7.2.1. Global Fertility Drugs by: Type (Value)
        • 7.2.1.1. Prescription Fertility Drugs
        • 7.2.1.2. Over-The-Counter Fertility drugs
      • 7.2.2. Global Fertility Drugs by: Application (Value)
        • 7.2.2.1. Fertility Centers
        • 7.2.2.2. Hospitals & Surgical Clinics
        • 7.2.2.3. Cryobanks
        • 7.2.2.4. Research Institutes
      • 7.2.3. Global Fertility Drugs by: Patient Type (Value)
        • 7.2.3.1. Female fertility
        • 7.2.3.2. Male fertility
      • 7.2.4. Global Fertility Drugs by: Route of Administration (Value)
        • 7.2.4.1. Intravenous
        • 7.2.4.2. Subcutaneous
        • 7.2.4.3. Intramuscular
      • 7.2.5. Global Fertility Drugs by: Use ` (Value)
        • 7.2.5.1. Metformin (Glucophage)
        • 7.2.5.2. Dopamine agonists
        • 7.2.5.3. Clomiphene (Clomid):
        • 7.2.5.4. Letrozole (Femara)
        • 7.2.5.5. Gonadotropin
      • 7.2.6. Global Fertility Drugs Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Fertility Drugs (Volume)
      • 7.3.1. Global Fertility Drugs by: Type (Volume)
        • 7.3.1.1. Prescription Fertility Drugs
        • 7.3.1.2. Over-The-Counter Fertility drugs
      • 7.3.2. Global Fertility Drugs by: Application (Volume)
        • 7.3.2.1. Fertility Centers
        • 7.3.2.2. Hospitals & Surgical Clinics
        • 7.3.2.3. Cryobanks
        • 7.3.2.4. Research Institutes
      • 7.3.3. Global Fertility Drugs by: Patient Type (Volume)
        • 7.3.3.1. Female fertility
        • 7.3.3.2. Male fertility
      • 7.3.4. Global Fertility Drugs by: Route of Administration (Volume)
        • 7.3.4.1. Intravenous
        • 7.3.4.2. Subcutaneous
        • 7.3.4.3. Intramuscular
      • 7.3.5. Global Fertility Drugs by: Use ` (Volume)
        • 7.3.5.1. Metformin (Glucophage)
        • 7.3.5.2. Dopamine agonists
        • 7.3.5.3. Clomiphene (Clomid):
        • 7.3.5.4. Letrozole (Femara)
        • 7.3.5.5. Gonadotropin
      • 7.3.6. Global Fertility Drugs Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Fertility Drugs (Price)
      • 7.4.1. Global Fertility Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fertility Drugs: by Type(USD Million)
  • Table 2. Fertility Drugs Prescription Fertility Drugs , by Region USD Million (2014-2019)
  • Table 3. Fertility Drugs Over-The-Counter Fertility drugs , by Region USD Million (2014-2019)
  • Table 4. Fertility Drugs: by Application(USD Million)
  • Table 5. Fertility Drugs Fertility Centers , by Region USD Million (2014-2019)
  • Table 6. Fertility Drugs Hospitals & Surgical Clinics , by Region USD Million (2014-2019)
  • Table 7. Fertility Drugs Cryobanks , by Region USD Million (2014-2019)
  • Table 8. Fertility Drugs Research Institutes , by Region USD Million (2014-2019)
  • Table 9. Fertility Drugs: by Patient Type(USD Million)
  • Table 10. Fertility Drugs Female fertility , by Region USD Million (2014-2019)
  • Table 11. Fertility Drugs Male fertility , by Region USD Million (2014-2019)
  • Table 12. Fertility Drugs: by Route of Administration(USD Million)
  • Table 13. Fertility Drugs Intravenous , by Region USD Million (2014-2019)
  • Table 14. Fertility Drugs Subcutaneous , by Region USD Million (2014-2019)
  • Table 15. Fertility Drugs Intramuscular , by Region USD Million (2014-2019)
  • Table 16. Fertility Drugs: by Use `(USD Million)
  • Table 17. Fertility Drugs Metformin (Glucophage) , by Region USD Million (2014-2019)
  • Table 18. Fertility Drugs Dopamine agonists , by Region USD Million (2014-2019)
  • Table 19. Fertility Drugs Clomiphene (Clomid): , by Region USD Million (2014-2019)
  • Table 20. Fertility Drugs Letrozole (Femara) , by Region USD Million (2014-2019)
  • Table 21. Fertility Drugs Gonadotropin , by Region USD Million (2014-2019)
  • Table 22. South America Fertility Drugs, by Country USD Million (2014-2019)
  • Table 23. South America Fertility Drugs, by Type USD Million (2014-2019)
  • Table 24. South America Fertility Drugs, by Application USD Million (2014-2019)
  • Table 25. South America Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 26. South America Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 27. South America Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 28. Brazil Fertility Drugs, by Type USD Million (2014-2019)
  • Table 29. Brazil Fertility Drugs, by Application USD Million (2014-2019)
  • Table 30. Brazil Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 31. Brazil Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 32. Brazil Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 33. Argentina Fertility Drugs, by Type USD Million (2014-2019)
  • Table 34. Argentina Fertility Drugs, by Application USD Million (2014-2019)
  • Table 35. Argentina Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 36. Argentina Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 37. Argentina Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 38. Rest of South America Fertility Drugs, by Type USD Million (2014-2019)
  • Table 39. Rest of South America Fertility Drugs, by Application USD Million (2014-2019)
  • Table 40. Rest of South America Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 41. Rest of South America Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 42. Rest of South America Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 43. Asia Pacific Fertility Drugs, by Country USD Million (2014-2019)
  • Table 44. Asia Pacific Fertility Drugs, by Type USD Million (2014-2019)
  • Table 45. Asia Pacific Fertility Drugs, by Application USD Million (2014-2019)
  • Table 46. Asia Pacific Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 47. Asia Pacific Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 48. Asia Pacific Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 49. China Fertility Drugs, by Type USD Million (2014-2019)
  • Table 50. China Fertility Drugs, by Application USD Million (2014-2019)
  • Table 51. China Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 52. China Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 53. China Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 54. Japan Fertility Drugs, by Type USD Million (2014-2019)
  • Table 55. Japan Fertility Drugs, by Application USD Million (2014-2019)
  • Table 56. Japan Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 57. Japan Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 58. Japan Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 59. India Fertility Drugs, by Type USD Million (2014-2019)
  • Table 60. India Fertility Drugs, by Application USD Million (2014-2019)
  • Table 61. India Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 62. India Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 63. India Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 64. South Korea Fertility Drugs, by Type USD Million (2014-2019)
  • Table 65. South Korea Fertility Drugs, by Application USD Million (2014-2019)
  • Table 66. South Korea Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 67. South Korea Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 68. South Korea Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 69. Taiwan Fertility Drugs, by Type USD Million (2014-2019)
  • Table 70. Taiwan Fertility Drugs, by Application USD Million (2014-2019)
  • Table 71. Taiwan Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 72. Taiwan Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 73. Taiwan Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 74. Australia Fertility Drugs, by Type USD Million (2014-2019)
  • Table 75. Australia Fertility Drugs, by Application USD Million (2014-2019)
  • Table 76. Australia Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 77. Australia Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 78. Australia Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 79. Rest of Asia-Pacific Fertility Drugs, by Type USD Million (2014-2019)
  • Table 80. Rest of Asia-Pacific Fertility Drugs, by Application USD Million (2014-2019)
  • Table 81. Rest of Asia-Pacific Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 82. Rest of Asia-Pacific Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 83. Rest of Asia-Pacific Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 84. Europe Fertility Drugs, by Country USD Million (2014-2019)
  • Table 85. Europe Fertility Drugs, by Type USD Million (2014-2019)
  • Table 86. Europe Fertility Drugs, by Application USD Million (2014-2019)
  • Table 87. Europe Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 88. Europe Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 89. Europe Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 90. Germany Fertility Drugs, by Type USD Million (2014-2019)
  • Table 91. Germany Fertility Drugs, by Application USD Million (2014-2019)
  • Table 92. Germany Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 93. Germany Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 94. Germany Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 95. France Fertility Drugs, by Type USD Million (2014-2019)
  • Table 96. France Fertility Drugs, by Application USD Million (2014-2019)
  • Table 97. France Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 98. France Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 99. France Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 100. Italy Fertility Drugs, by Type USD Million (2014-2019)
  • Table 101. Italy Fertility Drugs, by Application USD Million (2014-2019)
  • Table 102. Italy Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 103. Italy Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 104. Italy Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 105. United Kingdom Fertility Drugs, by Type USD Million (2014-2019)
  • Table 106. United Kingdom Fertility Drugs, by Application USD Million (2014-2019)
  • Table 107. United Kingdom Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 108. United Kingdom Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 109. United Kingdom Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 110. Netherlands Fertility Drugs, by Type USD Million (2014-2019)
  • Table 111. Netherlands Fertility Drugs, by Application USD Million (2014-2019)
  • Table 112. Netherlands Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 113. Netherlands Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 114. Netherlands Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 115. Rest of Europe Fertility Drugs, by Type USD Million (2014-2019)
  • Table 116. Rest of Europe Fertility Drugs, by Application USD Million (2014-2019)
  • Table 117. Rest of Europe Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 118. Rest of Europe Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 119. Rest of Europe Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 120. MEA Fertility Drugs, by Country USD Million (2014-2019)
  • Table 121. MEA Fertility Drugs, by Type USD Million (2014-2019)
  • Table 122. MEA Fertility Drugs, by Application USD Million (2014-2019)
  • Table 123. MEA Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 124. MEA Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 125. MEA Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 126. Middle East Fertility Drugs, by Type USD Million (2014-2019)
  • Table 127. Middle East Fertility Drugs, by Application USD Million (2014-2019)
  • Table 128. Middle East Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 129. Middle East Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 130. Middle East Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 131. Africa Fertility Drugs, by Type USD Million (2014-2019)
  • Table 132. Africa Fertility Drugs, by Application USD Million (2014-2019)
  • Table 133. Africa Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 134. Africa Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 135. Africa Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 136. North America Fertility Drugs, by Country USD Million (2014-2019)
  • Table 137. North America Fertility Drugs, by Type USD Million (2014-2019)
  • Table 138. North America Fertility Drugs, by Application USD Million (2014-2019)
  • Table 139. North America Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 140. North America Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 141. North America Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 142. United States Fertility Drugs, by Type USD Million (2014-2019)
  • Table 143. United States Fertility Drugs, by Application USD Million (2014-2019)
  • Table 144. United States Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 145. United States Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 146. United States Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 147. Canada Fertility Drugs, by Type USD Million (2014-2019)
  • Table 148. Canada Fertility Drugs, by Application USD Million (2014-2019)
  • Table 149. Canada Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 150. Canada Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 151. Canada Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 152. Mexico Fertility Drugs, by Type USD Million (2014-2019)
  • Table 153. Mexico Fertility Drugs, by Application USD Million (2014-2019)
  • Table 154. Mexico Fertility Drugs, by Patient Type USD Million (2014-2019)
  • Table 155. Mexico Fertility Drugs, by Route of Administration USD Million (2014-2019)
  • Table 156. Mexico Fertility Drugs, by Use ` USD Million (2014-2019)
  • Table 157. Fertility Drugs Sales: by Type(K Tons)
  • Table 158. Fertility Drugs Sales Prescription Fertility Drugs , by Region K Tons (2014-2019)
  • Table 159. Fertility Drugs Sales Over-The-Counter Fertility drugs , by Region K Tons (2014-2019)
  • Table 160. Fertility Drugs Sales: by Application(K Tons)
  • Table 161. Fertility Drugs Sales Fertility Centers , by Region K Tons (2014-2019)
  • Table 162. Fertility Drugs Sales Hospitals & Surgical Clinics , by Region K Tons (2014-2019)
  • Table 163. Fertility Drugs Sales Cryobanks , by Region K Tons (2014-2019)
  • Table 164. Fertility Drugs Sales Research Institutes , by Region K Tons (2014-2019)
  • Table 165. Fertility Drugs Sales: by Patient Type(K Tons)
  • Table 166. Fertility Drugs Sales Female fertility , by Region K Tons (2014-2019)
  • Table 167. Fertility Drugs Sales Male fertility , by Region K Tons (2014-2019)
  • Table 168. Fertility Drugs Sales: by Route of Administration(K Tons)
  • Table 169. Fertility Drugs Sales Intravenous , by Region K Tons (2014-2019)
  • Table 170. Fertility Drugs Sales Subcutaneous , by Region K Tons (2014-2019)
  • Table 171. Fertility Drugs Sales Intramuscular , by Region K Tons (2014-2019)
  • Table 172. Fertility Drugs Sales: by Use `(K Tons)
  • Table 173. Fertility Drugs Sales Metformin (Glucophage) , by Region K Tons (2014-2019)
  • Table 174. Fertility Drugs Sales Dopamine agonists , by Region K Tons (2014-2019)
  • Table 175. Fertility Drugs Sales Clomiphene (Clomid): , by Region K Tons (2014-2019)
  • Table 176. Fertility Drugs Sales Letrozole (Femara) , by Region K Tons (2014-2019)
  • Table 177. Fertility Drugs Sales Gonadotropin , by Region K Tons (2014-2019)
  • Table 178. South America Fertility Drugs Sales, by Country K Tons (2014-2019)
  • Table 179. South America Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 180. South America Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 181. South America Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 182. South America Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 183. South America Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 184. Brazil Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 185. Brazil Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 186. Brazil Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 187. Brazil Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 188. Brazil Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 189. Argentina Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 190. Argentina Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 191. Argentina Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 192. Argentina Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 193. Argentina Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 194. Rest of South America Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 195. Rest of South America Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 196. Rest of South America Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 197. Rest of South America Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 198. Rest of South America Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 199. Asia Pacific Fertility Drugs Sales, by Country K Tons (2014-2019)
  • Table 200. Asia Pacific Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 201. Asia Pacific Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 202. Asia Pacific Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 203. Asia Pacific Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 204. Asia Pacific Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 205. China Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 206. China Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 207. China Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 208. China Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 209. China Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 210. Japan Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 211. Japan Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 212. Japan Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 213. Japan Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 214. Japan Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 215. India Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 216. India Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 217. India Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 218. India Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 219. India Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 220. South Korea Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 221. South Korea Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 222. South Korea Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 223. South Korea Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 224. South Korea Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 225. Taiwan Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 226. Taiwan Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 227. Taiwan Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 228. Taiwan Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 229. Taiwan Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 230. Australia Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 231. Australia Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 232. Australia Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 233. Australia Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 234. Australia Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 235. Rest of Asia-Pacific Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 236. Rest of Asia-Pacific Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 237. Rest of Asia-Pacific Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 238. Rest of Asia-Pacific Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 239. Rest of Asia-Pacific Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 240. Europe Fertility Drugs Sales, by Country K Tons (2014-2019)
  • Table 241. Europe Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 242. Europe Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 243. Europe Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 244. Europe Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 245. Europe Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 246. Germany Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 247. Germany Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 248. Germany Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 249. Germany Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 250. Germany Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 251. France Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 252. France Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 253. France Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 254. France Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 255. France Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 256. Italy Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 257. Italy Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 258. Italy Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 259. Italy Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 260. Italy Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 261. United Kingdom Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 262. United Kingdom Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 263. United Kingdom Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 264. United Kingdom Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 265. United Kingdom Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 266. Netherlands Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 267. Netherlands Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 268. Netherlands Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 269. Netherlands Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 270. Netherlands Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 271. Rest of Europe Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 272. Rest of Europe Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 273. Rest of Europe Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 274. Rest of Europe Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 275. Rest of Europe Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 276. MEA Fertility Drugs Sales, by Country K Tons (2014-2019)
  • Table 277. MEA Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 278. MEA Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 279. MEA Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 280. MEA Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 281. MEA Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 282. Middle East Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 283. Middle East Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 284. Middle East Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 285. Middle East Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 286. Middle East Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 287. Africa Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 288. Africa Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 289. Africa Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 290. Africa Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 291. Africa Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 292. North America Fertility Drugs Sales, by Country K Tons (2014-2019)
  • Table 293. North America Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 294. North America Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 295. North America Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 296. North America Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 297. North America Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 298. United States Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 299. United States Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 300. United States Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 301. United States Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 302. United States Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 303. Canada Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 304. Canada Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 305. Canada Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 306. Canada Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 307. Canada Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 308. Mexico Fertility Drugs Sales, by Type K Tons (2014-2019)
  • Table 309. Mexico Fertility Drugs Sales, by Application K Tons (2014-2019)
  • Table 310. Mexico Fertility Drugs Sales, by Patient Type K Tons (2014-2019)
  • Table 311. Mexico Fertility Drugs Sales, by Route of Administration K Tons (2014-2019)
  • Table 312. Mexico Fertility Drugs Sales, by Use ` K Tons (2014-2019)
  • Table 313. Fertility Drugs: by Type(USD/Units)
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Company Basic Information, Sales Area and Its Competitors
  • Table 317. Company Basic Information, Sales Area and Its Competitors
  • Table 318. Company Basic Information, Sales Area and Its Competitors
  • Table 319. Company Basic Information, Sales Area and Its Competitors
  • Table 320. Company Basic Information, Sales Area and Its Competitors
  • Table 321. Company Basic Information, Sales Area and Its Competitors
  • Table 322. Company Basic Information, Sales Area and Its Competitors
  • Table 323. Company Basic Information, Sales Area and Its Competitors
  • Table 324. Fertility Drugs: by Type(USD Million)
  • Table 325. Fertility Drugs Prescription Fertility Drugs , by Region USD Million (2020-2025)
  • Table 326. Fertility Drugs Over-The-Counter Fertility drugs , by Region USD Million (2020-2025)
  • Table 327. Fertility Drugs: by Application(USD Million)
  • Table 328. Fertility Drugs Fertility Centers , by Region USD Million (2020-2025)
  • Table 329. Fertility Drugs Hospitals & Surgical Clinics , by Region USD Million (2020-2025)
  • Table 330. Fertility Drugs Cryobanks , by Region USD Million (2020-2025)
  • Table 331. Fertility Drugs Research Institutes , by Region USD Million (2020-2025)
  • Table 332. Fertility Drugs: by Patient Type(USD Million)
  • Table 333. Fertility Drugs Female fertility , by Region USD Million (2020-2025)
  • Table 334. Fertility Drugs Male fertility , by Region USD Million (2020-2025)
  • Table 335. Fertility Drugs: by Route of Administration(USD Million)
  • Table 336. Fertility Drugs Intravenous , by Region USD Million (2020-2025)
  • Table 337. Fertility Drugs Subcutaneous , by Region USD Million (2020-2025)
  • Table 338. Fertility Drugs Intramuscular , by Region USD Million (2020-2025)
  • Table 339. Fertility Drugs: by Use `(USD Million)
  • Table 340. Fertility Drugs Metformin (Glucophage) , by Region USD Million (2020-2025)
  • Table 341. Fertility Drugs Dopamine agonists , by Region USD Million (2020-2025)
  • Table 342. Fertility Drugs Clomiphene (Clomid): , by Region USD Million (2020-2025)
  • Table 343. Fertility Drugs Letrozole (Femara) , by Region USD Million (2020-2025)
  • Table 344. Fertility Drugs Gonadotropin , by Region USD Million (2020-2025)
  • Table 345. South America Fertility Drugs, by Country USD Million (2020-2025)
  • Table 346. South America Fertility Drugs, by Type USD Million (2020-2025)
  • Table 347. South America Fertility Drugs, by Application USD Million (2020-2025)
  • Table 348. South America Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 349. South America Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 350. South America Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 351. Brazil Fertility Drugs, by Type USD Million (2020-2025)
  • Table 352. Brazil Fertility Drugs, by Application USD Million (2020-2025)
  • Table 353. Brazil Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 354. Brazil Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 355. Brazil Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 356. Argentina Fertility Drugs, by Type USD Million (2020-2025)
  • Table 357. Argentina Fertility Drugs, by Application USD Million (2020-2025)
  • Table 358. Argentina Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 359. Argentina Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 360. Argentina Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 361. Rest of South America Fertility Drugs, by Type USD Million (2020-2025)
  • Table 362. Rest of South America Fertility Drugs, by Application USD Million (2020-2025)
  • Table 363. Rest of South America Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 364. Rest of South America Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 365. Rest of South America Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 366. Asia Pacific Fertility Drugs, by Country USD Million (2020-2025)
  • Table 367. Asia Pacific Fertility Drugs, by Type USD Million (2020-2025)
  • Table 368. Asia Pacific Fertility Drugs, by Application USD Million (2020-2025)
  • Table 369. Asia Pacific Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 370. Asia Pacific Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 371. Asia Pacific Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 372. China Fertility Drugs, by Type USD Million (2020-2025)
  • Table 373. China Fertility Drugs, by Application USD Million (2020-2025)
  • Table 374. China Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 375. China Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 376. China Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 377. Japan Fertility Drugs, by Type USD Million (2020-2025)
  • Table 378. Japan Fertility Drugs, by Application USD Million (2020-2025)
  • Table 379. Japan Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 380. Japan Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 381. Japan Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 382. India Fertility Drugs, by Type USD Million (2020-2025)
  • Table 383. India Fertility Drugs, by Application USD Million (2020-2025)
  • Table 384. India Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 385. India Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 386. India Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 387. South Korea Fertility Drugs, by Type USD Million (2020-2025)
  • Table 388. South Korea Fertility Drugs, by Application USD Million (2020-2025)
  • Table 389. South Korea Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 390. South Korea Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 391. South Korea Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 392. Taiwan Fertility Drugs, by Type USD Million (2020-2025)
  • Table 393. Taiwan Fertility Drugs, by Application USD Million (2020-2025)
  • Table 394. Taiwan Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 395. Taiwan Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 396. Taiwan Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 397. Australia Fertility Drugs, by Type USD Million (2020-2025)
  • Table 398. Australia Fertility Drugs, by Application USD Million (2020-2025)
  • Table 399. Australia Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 400. Australia Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 401. Australia Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 402. Rest of Asia-Pacific Fertility Drugs, by Type USD Million (2020-2025)
  • Table 403. Rest of Asia-Pacific Fertility Drugs, by Application USD Million (2020-2025)
  • Table 404. Rest of Asia-Pacific Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 405. Rest of Asia-Pacific Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 406. Rest of Asia-Pacific Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 407. Europe Fertility Drugs, by Country USD Million (2020-2025)
  • Table 408. Europe Fertility Drugs, by Type USD Million (2020-2025)
  • Table 409. Europe Fertility Drugs, by Application USD Million (2020-2025)
  • Table 410. Europe Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 411. Europe Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 412. Europe Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 413. Germany Fertility Drugs, by Type USD Million (2020-2025)
  • Table 414. Germany Fertility Drugs, by Application USD Million (2020-2025)
  • Table 415. Germany Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 416. Germany Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 417. Germany Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 418. France Fertility Drugs, by Type USD Million (2020-2025)
  • Table 419. France Fertility Drugs, by Application USD Million (2020-2025)
  • Table 420. France Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 421. France Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 422. France Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 423. Italy Fertility Drugs, by Type USD Million (2020-2025)
  • Table 424. Italy Fertility Drugs, by Application USD Million (2020-2025)
  • Table 425. Italy Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 426. Italy Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 427. Italy Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 428. United Kingdom Fertility Drugs, by Type USD Million (2020-2025)
  • Table 429. United Kingdom Fertility Drugs, by Application USD Million (2020-2025)
  • Table 430. United Kingdom Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 431. United Kingdom Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 432. United Kingdom Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 433. Netherlands Fertility Drugs, by Type USD Million (2020-2025)
  • Table 434. Netherlands Fertility Drugs, by Application USD Million (2020-2025)
  • Table 435. Netherlands Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 436. Netherlands Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 437. Netherlands Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 438. Rest of Europe Fertility Drugs, by Type USD Million (2020-2025)
  • Table 439. Rest of Europe Fertility Drugs, by Application USD Million (2020-2025)
  • Table 440. Rest of Europe Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 441. Rest of Europe Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 442. Rest of Europe Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 443. MEA Fertility Drugs, by Country USD Million (2020-2025)
  • Table 444. MEA Fertility Drugs, by Type USD Million (2020-2025)
  • Table 445. MEA Fertility Drugs, by Application USD Million (2020-2025)
  • Table 446. MEA Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 447. MEA Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 448. MEA Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 449. Middle East Fertility Drugs, by Type USD Million (2020-2025)
  • Table 450. Middle East Fertility Drugs, by Application USD Million (2020-2025)
  • Table 451. Middle East Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 452. Middle East Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 453. Middle East Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 454. Africa Fertility Drugs, by Type USD Million (2020-2025)
  • Table 455. Africa Fertility Drugs, by Application USD Million (2020-2025)
  • Table 456. Africa Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 457. Africa Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 458. Africa Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 459. North America Fertility Drugs, by Country USD Million (2020-2025)
  • Table 460. North America Fertility Drugs, by Type USD Million (2020-2025)
  • Table 461. North America Fertility Drugs, by Application USD Million (2020-2025)
  • Table 462. North America Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 463. North America Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 464. North America Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 465. United States Fertility Drugs, by Type USD Million (2020-2025)
  • Table 466. United States Fertility Drugs, by Application USD Million (2020-2025)
  • Table 467. United States Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 468. United States Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 469. United States Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 470. Canada Fertility Drugs, by Type USD Million (2020-2025)
  • Table 471. Canada Fertility Drugs, by Application USD Million (2020-2025)
  • Table 472. Canada Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 473. Canada Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 474. Canada Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 475. Mexico Fertility Drugs, by Type USD Million (2020-2025)
  • Table 476. Mexico Fertility Drugs, by Application USD Million (2020-2025)
  • Table 477. Mexico Fertility Drugs, by Patient Type USD Million (2020-2025)
  • Table 478. Mexico Fertility Drugs, by Route of Administration USD Million (2020-2025)
  • Table 479. Mexico Fertility Drugs, by Use ` USD Million (2020-2025)
  • Table 480. Fertility Drugs Sales: by Type(K Tons)
  • Table 481. Fertility Drugs Sales Prescription Fertility Drugs , by Region K Tons (2020-2025)
  • Table 482. Fertility Drugs Sales Over-The-Counter Fertility drugs , by Region K Tons (2020-2025)
  • Table 483. Fertility Drugs Sales: by Application(K Tons)
  • Table 484. Fertility Drugs Sales Fertility Centers , by Region K Tons (2020-2025)
  • Table 485. Fertility Drugs Sales Hospitals & Surgical Clinics , by Region K Tons (2020-2025)
  • Table 486. Fertility Drugs Sales Cryobanks , by Region K Tons (2020-2025)
  • Table 487. Fertility Drugs Sales Research Institutes , by Region K Tons (2020-2025)
  • Table 488. Fertility Drugs Sales: by Patient Type(K Tons)
  • Table 489. Fertility Drugs Sales Female fertility , by Region K Tons (2020-2025)
  • Table 490. Fertility Drugs Sales Male fertility , by Region K Tons (2020-2025)
  • Table 491. Fertility Drugs Sales: by Route of Administration(K Tons)
  • Table 492. Fertility Drugs Sales Intravenous , by Region K Tons (2020-2025)
  • Table 493. Fertility Drugs Sales Subcutaneous , by Region K Tons (2020-2025)
  • Table 494. Fertility Drugs Sales Intramuscular , by Region K Tons (2020-2025)
  • Table 495. Fertility Drugs Sales: by Use `(K Tons)
  • Table 496. Fertility Drugs Sales Metformin (Glucophage) , by Region K Tons (2020-2025)
  • Table 497. Fertility Drugs Sales Dopamine agonists , by Region K Tons (2020-2025)
  • Table 498. Fertility Drugs Sales Clomiphene (Clomid): , by Region K Tons (2020-2025)
  • Table 499. Fertility Drugs Sales Letrozole (Femara) , by Region K Tons (2020-2025)
  • Table 500. Fertility Drugs Sales Gonadotropin , by Region K Tons (2020-2025)
  • Table 501. South America Fertility Drugs Sales, by Country K Tons (2020-2025)
  • Table 502. South America Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 503. South America Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 504. South America Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 505. South America Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 506. South America Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 507. Brazil Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 508. Brazil Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 509. Brazil Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 510. Brazil Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 511. Brazil Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 512. Argentina Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 513. Argentina Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 514. Argentina Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 515. Argentina Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 516. Argentina Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 517. Rest of South America Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 518. Rest of South America Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 519. Rest of South America Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 520. Rest of South America Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 521. Rest of South America Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 522. Asia Pacific Fertility Drugs Sales, by Country K Tons (2020-2025)
  • Table 523. Asia Pacific Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 524. Asia Pacific Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 525. Asia Pacific Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 526. Asia Pacific Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 527. Asia Pacific Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 528. China Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 529. China Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 530. China Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 531. China Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 532. China Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 533. Japan Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 534. Japan Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 535. Japan Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 536. Japan Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 537. Japan Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 538. India Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 539. India Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 540. India Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 541. India Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 542. India Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 543. South Korea Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 544. South Korea Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 545. South Korea Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 546. South Korea Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 547. South Korea Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 548. Taiwan Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 549. Taiwan Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 550. Taiwan Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 551. Taiwan Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 552. Taiwan Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 553. Australia Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 554. Australia Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 555. Australia Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 556. Australia Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 557. Australia Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 558. Rest of Asia-Pacific Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 559. Rest of Asia-Pacific Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 560. Rest of Asia-Pacific Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 561. Rest of Asia-Pacific Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 562. Rest of Asia-Pacific Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 563. Europe Fertility Drugs Sales, by Country K Tons (2020-2025)
  • Table 564. Europe Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 565. Europe Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 566. Europe Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 567. Europe Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 568. Europe Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 569. Germany Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 570. Germany Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 571. Germany Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 572. Germany Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 573. Germany Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 574. France Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 575. France Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 576. France Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 577. France Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 578. France Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 579. Italy Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 580. Italy Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 581. Italy Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 582. Italy Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 583. Italy Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 584. United Kingdom Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 585. United Kingdom Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 586. United Kingdom Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 587. United Kingdom Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 588. United Kingdom Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 589. Netherlands Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 590. Netherlands Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 591. Netherlands Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 592. Netherlands Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 593. Netherlands Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 594. Rest of Europe Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 595. Rest of Europe Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 596. Rest of Europe Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 597. Rest of Europe Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 598. Rest of Europe Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 599. MEA Fertility Drugs Sales, by Country K Tons (2020-2025)
  • Table 600. MEA Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 601. MEA Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 602. MEA Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 603. MEA Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 604. MEA Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 605. Middle East Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 606. Middle East Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 607. Middle East Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 608. Middle East Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 609. Middle East Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 610. Africa Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 611. Africa Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 612. Africa Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 613. Africa Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 614. Africa Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 615. North America Fertility Drugs Sales, by Country K Tons (2020-2025)
  • Table 616. North America Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 617. North America Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 618. North America Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 619. North America Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 620. North America Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 621. United States Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 622. United States Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 623. United States Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 624. United States Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 625. United States Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 626. Canada Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 627. Canada Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 628. Canada Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 629. Canada Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 630. Canada Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 631. Mexico Fertility Drugs Sales, by Type K Tons (2020-2025)
  • Table 632. Mexico Fertility Drugs Sales, by Application K Tons (2020-2025)
  • Table 633. Mexico Fertility Drugs Sales, by Patient Type K Tons (2020-2025)
  • Table 634. Mexico Fertility Drugs Sales, by Route of Administration K Tons (2020-2025)
  • Table 635. Mexico Fertility Drugs Sales, by Use ` K Tons (2020-2025)
  • Table 636. Fertility Drugs: by Type(USD/Units)
  • Table 637. Research Programs/Design for This Report
  • Table 638. Key Data Information from Secondary Sources
  • Table 639. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fertility Drugs: by Type USD Million (2014-2019)
  • Figure 5. Global Fertility Drugs: by Application USD Million (2014-2019)
  • Figure 6. Global Fertility Drugs: by Patient Type USD Million (2014-2019)
  • Figure 7. Global Fertility Drugs: by Route of Administration USD Million (2014-2019)
  • Figure 8. Global Fertility Drugs: by Use ` USD Million (2014-2019)
  • Figure 9. South America Fertility Drugs Share (%), by Country
  • Figure 10. Asia Pacific Fertility Drugs Share (%), by Country
  • Figure 11. Europe Fertility Drugs Share (%), by Country
  • Figure 12. MEA Fertility Drugs Share (%), by Country
  • Figure 13. North America Fertility Drugs Share (%), by Country
  • Figure 14. Global Fertility Drugs: by Type K Tons (2014-2019)
  • Figure 15. Global Fertility Drugs: by Application K Tons (2014-2019)
  • Figure 16. Global Fertility Drugs: by Patient Type K Tons (2014-2019)
  • Figure 17. Global Fertility Drugs: by Route of Administration K Tons (2014-2019)
  • Figure 18. Global Fertility Drugs: by Use ` K Tons (2014-2019)
  • Figure 19. South America Fertility Drugs Share (%), by Country
  • Figure 20. Asia Pacific Fertility Drugs Share (%), by Country
  • Figure 21. Europe Fertility Drugs Share (%), by Country
  • Figure 22. MEA Fertility Drugs Share (%), by Country
  • Figure 23. North America Fertility Drugs Share (%), by Country
  • Figure 24. Global Fertility Drugs: by Type USD/Units (2014-2019)
  • Figure 25. Global Fertility Drugs share by Players 2019 (%)
  • Figure 26. Global Fertility Drugs share by Players (Top 3) 2019(%)
  • Figure 27. Global Fertility Drugs share by Players (Top 5) 2019(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Merck & Co. (United States) Revenue: by Geography 2019
  • Figure 31. Ferring Pharmaceuticals (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Ferring Pharmaceuticals (Switzerland) Revenue: by Geography 2019
  • Figure 33. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Bayer (Germany) Revenue: by Geography 2019
  • Figure 35. Berlex Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Berlex Laboratories Inc. (United States) Revenue: by Geography 2019
  • Figure 37. Janssen Pharmaceutical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Janssen Pharmaceutical Inc. (United States) Revenue: by Geography 2019
  • Figure 39. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 40. Pfizer (United States) Revenue: by Geography 2019
  • Figure 41. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 42. Novartis AG (Switzerland) Revenue: by Geography 2019
  • Figure 43. Procter & Gamble Pharmaceutical (United States) Revenue, Net Income and Gross profit
  • Figure 44. Procter & Gamble Pharmaceutical (United States) Revenue: by Geography 2019
  • Figure 45. Sanofi S.A (France) Revenue, Net Income and Gross profit
  • Figure 46. Sanofi S.A (France) Revenue: by Geography 2019
  • Figure 47. Eli Lilly and Co.(United States) Revenue, Net Income and Gross profit
  • Figure 48. Eli Lilly and Co.(United States) Revenue: by Geography 2019
  • Figure 49. Global Fertility Drugs: by Type USD Million (2020-2025)
  • Figure 50. Global Fertility Drugs: by Application USD Million (2020-2025)
  • Figure 51. Global Fertility Drugs: by Patient Type USD Million (2020-2025)
  • Figure 52. Global Fertility Drugs: by Route of Administration USD Million (2020-2025)
  • Figure 53. Global Fertility Drugs: by Use ` USD Million (2020-2025)
  • Figure 54. South America Fertility Drugs Share (%), by Country
  • Figure 55. Asia Pacific Fertility Drugs Share (%), by Country
  • Figure 56. Europe Fertility Drugs Share (%), by Country
  • Figure 57. MEA Fertility Drugs Share (%), by Country
  • Figure 58. North America Fertility Drugs Share (%), by Country
  • Figure 59. Global Fertility Drugs: by Type K Tons (2020-2025)
  • Figure 60. Global Fertility Drugs: by Application K Tons (2020-2025)
  • Figure 61. Global Fertility Drugs: by Patient Type K Tons (2020-2025)
  • Figure 62. Global Fertility Drugs: by Route of Administration K Tons (2020-2025)
  • Figure 63. Global Fertility Drugs: by Use ` K Tons (2020-2025)
  • Figure 64. South America Fertility Drugs Share (%), by Country
  • Figure 65. Asia Pacific Fertility Drugs Share (%), by Country
  • Figure 66. Europe Fertility Drugs Share (%), by Country
  • Figure 67. MEA Fertility Drugs Share (%), by Country
  • Figure 68. North America Fertility Drugs Share (%), by Country
  • Figure 69. Global Fertility Drugs: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Merck & Co. (United States)
  • Ferring Pharmaceuticals (Switzerland)
  • Bayer (Germany)
  • Berlex Laboratories Inc. (United States)
  • Janssen Pharmaceutical Inc. (United States)
  • Pfizer (United States)
  • Novartis AG (Switzerland)
  • Procter & Gamble Pharmaceutical (United States)
  • Sanofi S.A (France)
  • Eli Lilly and Co.(United States)
Additional players considered in the study are as follows:
Livzon Pharmaceutical Group Co., Ltd.(China)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation